LINCOLN, Mass., Aug. 29, 2017 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, today announced the kickoff of their 2017-2018 QSP Industry and Academia Symposium series. The first symposium of the series will be held Tuesday, October 24, 2017 from 5:00 p.m. – 7:30 p.m. at the Cambridge Innovation Center located in Cambridge, MA.
In its third year, the series continues to develop an active community of industry and academic participants interested in QSP and create a forum for sharing successes and challenges. Each symposium is typically comprised of two presentations from pharma and biotech researchers, along with networking opportunities. This QSP Industry and Academia Symposium will feature presentations from Madhu Natarajan, PhD, Head of Ophthalmology and Complement Therapeutic Areas Research at Shire Pharmaceuticals and Jishnu Das, PhD, Postdoctoral Associate at MIT.
Dr. Natarajan will present a talk titled "Why You Must 'Model for Modeling's Sake' and Other Career Advice for the Modeling Scientist" in which he will cover modeling vignettes from various projects to illustrate how his background in engineering theory, self-professed avoidance of biological pedagogy, and development of "minimal-complexity" models of biological systems have led him to become a useful manager of wet-bench biologists and drug hunters.
Dr. Das will present a talk titled "Studying the Immune System Using Computational Systems Biology Approaches" in which he will present examples of how computational systems biology approaches can be used to elucidate molecular mechanisms of both vaccine-mediated and natural immunity. Dr. Das' talk will encompass the challenges associated with the modeling methods, and how he attempted to overcome them. He will also discuss approaches that he used to translate core quantitative results into insights of potential biological significance.
"I am very excited to see that the symposium series has continued to flourish after our initial symposium three years ago. It is great to have industry and academic thought leaders come together to present and discuss findings as we continue to learn and support each other in this field, and also to see where Model Aided Drug Invention is, and where it is heading!"
John Burke, PhD, Co-Founder, President and CEO of Applied BioMath
For more information about this QSP Industry and Academia Symposium, and to register, please visit appliedbiomath.com/QSPIAS.
About Applied BioMath
Applied BioMath (www.appliedbiomath.com), the industry-leader in applying mechanistic modeling to drug research and development, helps biotechnology and pharmaceutical companies answer complex, critical Go/No-go decisions in R&D. Applied BioMath leverages biology, proprietary mathematical modeling and analysis technology, high-performance computing, and decades of industry experience to help groups better understand their candidate, its best-in-class parameters, competitive advantages, and the best path forward. Our involvement shortens project timelines, lowers cost, and increases the likelihood of a best-in-class drug. We provide clarity to complex situations, answer otherwise unanswerable questions, and our approach, when validated in the clinic, is 10x more accurate than traditional methodologies.
Applied BioMath and the Applied BioMath logo are trademarks of Applied BioMath, LLC.